AK Medical executes HKD 6.30 million share buyback; outstanding share count steady at 1.12 billion

Bulletin Express

May 15

AK Medical Holdings Limited reported to the Hong Kong Stock Exchange that it repurchased 1.00 million ordinary shares on 15 May 2026 at prices ranging between HKD 6.28 and HKD 6.35 per share, for a total consideration of HKD 6.30 million.

The buyback leaves the company’s issued share capital unchanged at 1,123.92 million shares, as the repurchased shares have not yet been cancelled. Including the latest transaction, AK Medical has bought back 7.58 million shares since the current mandate was approved on 18 June 2025, utilising 6.75 % of the 112.27 million shares authorised for repurchase.

All 7.58 million repurchased shares—equivalent to approximately 0.67 % of the company’s outstanding shares—remain pending cancellation. Under Hong Kong listing rules, AK Medical is subject to a moratorium on issuing new shares until 14 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1150247733"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150247733\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150247733?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150247733","market":"us","top_or_hot":-1,"title":"AK Medical executes HKD 6.30 million share buyback; outstanding share count steady at 1.12 billion","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited reported to the Hong Kong Stock Exchange that it repurchased 1.00 million ordinary shares on 15 May 2026 at prices ranging between HKD 6.28 and HKD 6.35 per share, for a total consideration of HKD 6.30 million.</p>\n<p>The buyback leaves the company’s issued share capital unchanged at 1,123.92 million shares, as the repurchased shares have not yet been cancelled. Including the latest transaction, AK Medical has bought back 7.58 million shares since the current mandate was approved on 18 June 2025, utilising 6.75 % of the 112.27 million shares authorised for repurchase.</p>\n<p>All 7.58 million repurchased shares—equivalent to approximately 0.67 % of the company’s outstanding shares—remain pending cancellation. Under Hong Kong listing rules, AK Medical is subject to a moratorium on issuing new shares until 14 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical executes HKD 6.30 million share buyback; outstanding share count steady at 1.12 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical executes HKD 6.30 million share buyback; outstanding share count steady at 1.12 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-15 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AK Medical Holdings Limited reported to the Hong Kong Stock Exchange that it repurchased 1.00 million ordinary shares on 15 May 2026 at prices ranging between HKD 6.28 and HKD 6.35 per share, for a total consideration of HKD 6.30 million.</p>\n<p>The buyback leaves the company’s issued share capital unchanged at 1,123.92 million shares, as the repurchased shares have not yet been cancelled. Including the latest transaction, AK Medical has bought back 7.58 million shares since the current mandate was approved on 18 June 2025, utilising 6.75 % of the 112.27 million shares authorised for repurchase.</p>\n<p>All 7.58 million repurchased shares—equivalent to approximately 0.67 % of the company’s outstanding shares—remain pending cancellation. Under Hong Kong listing rules, AK Medical is subject to a moratorium on issuing new shares until 14 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"","article_id":"1150247733","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150247733","pubTimestamp":1778845431,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited reported to the Hong Kong Stock Exchange that it repurchased 1.00 million ordinary shares on 15 May 2026 at prices ranging between HKD 6.28 and HKD 6.35 per share, for a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"爱康医疗执行630万港元股份回购；流通股数量稳定在11.2亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited reported to the Hong Kong Stock Exchange that it repurchased 1.00 million ordinary shares on 15 May 2026 at prices ranging between HKD 6.28 and HKD 6.35 per share, for a total consideration of HKD 6.30 million.\nThe buyback leaves the company’s issued share capital unchanged at 1,123.92 million shares, as the repurchased shares have not yet been cancelled. Including the latest transaction, AK Medical has bought back 7.58 million shares since the current mandate was approved on 18 June 2025, utilising 6.75 % of the 112.27 million shares authorised for repurchase.\nAll 7.58 million repurchased shares—equivalent to approximately 0.67 % of the company’s outstanding shares—remain pending cancellation. Under Hong Kong listing rules, AK Medical is subject to a moratorium on issuing new shares until 14 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}